Search

Your search keyword '"Behera, Madhusmita"' showing total 14 results
Start Over Author "Behera, Madhusmita" Journal cancer
14 results on '"Behera, Madhusmita"'

3. Next‐generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy

Author

Cassidy, Richard J., Zhang, Xinyan, Patel, Pretesh R., Shelton, Joseph W., Escott, Chase E., Sica, Gabriel L., Rossi, Michael R., Hill, Charles E., Steuer, Conor E., Pillai, Rathi N., Ramalingam, Suresh S., Owonikoko, Taofeek K., Behera, Madhusmita, Force, Seth D., Fernandez, Felix G., Curran, Walter J., and Higgins, Kristin A.

Published
2017
Full Text
View/download PDF

8. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification

Author

Press, Robert H., primary, Shafer, Sarah L., additional, Jiang, Renjian, additional, Buchwald, Zachary S., additional, Abugideiri, Mustafa, additional, Tian, Sibo, additional, Morgan, Tiffany M., additional, Behera, Madhusmita, additional, Sengupta, Soma, additional, Voloschin, Alfredo D., additional, Olson, Jeffrey J., additional, Hasan, Shaakir, additional, Blumenthal, Deborah T., additional, Curran, Walter J., additional, Eaton, Bree R., additional, Shu, Hui‐Kuo G., additional, and Zhong, Jim, additional

Published
2020
Full Text
View/download PDF

9. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy

Author

Tian, Sibo, primary, Jiang, Renjian, additional, Madden, Nicholas A., additional, Ferris, Matthew J., additional, Buchwald, Zachary S., additional, Xu, Karen M., additional, Cardona, Kenneth, additional, Maithel, Shishir K., additional, McDonald, Mark W., additional, Lin, Jolinta Y., additional, Curran, Walter J., additional, El‐Rayes, Bassel F., additional, Behera, Madhusmita, additional, and Patel, Pretesh R., additional

Published
2019
Full Text
View/download PDF

12. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium

Author

Steuer, Conor E., primary, Behera, Madhusmita, additional, Berry, Lynne, additional, Kim, Sungjin, additional, Rossi, Michael, additional, Sica, Gabriel, additional, Owonikoko, Taofeek K., additional, Johnson, Bruce E., additional, Kris, Mark G., additional, Bunn, Paul A., additional, Khuri, Fadlo R., additional, Garon, Edward B., additional, and Ramalingam, Suresh S., additional

Published
2015
Full Text
View/download PDF

13. Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005

Author

Behera, Madhusmita, primary, Ragin, Camille, additional, Kim, Sungjin, additional, Pillai, Rathi N., additional, Chen, Zhengjia, additional, Steuer, Conor E., additional, Saba, Nabil F., additional, Belani, Chandra P., additional, Khuri, Fadlo R., additional, Ramalingam, Suresh S., additional, and Owonikoko, Taofeek K., additional

Published
2015
Full Text
View/download PDF

14. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.

Author

Tian S, Jiang R, Madden NA, Ferris MJ, Buchwald ZS, Xu KM, Cardona K, Maithel SK, McDonald MW, Lin JY, Curran WJ, El-Rayes BF, Behera M, and Patel PR

Subjects
Adenocarcinoma pathology, Adenocarcinoma radiotherapy, Adenocarcinoma surgery, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Digestive System Surgical Procedures, Drug Therapy, Esophageal Neoplasms pathology, Esophageal Neoplasms radiotherapy, Esophageal Neoplasms surgery, Esophagogastric Junction drug effects, Esophagogastric Junction pathology, Esophagogastric Junction radiation effects, Esophagogastric Junction surgery, Female, Humans, Male, Middle Aged, Neoplasm Staging, Perioperative Period, Preoperative Period, Proportional Hazards Models, Stomach Neoplasms pathology, Stomach Neoplasms radiotherapy, Stomach Neoplasms surgery, Survival Rate, Treatment Outcome, Adenocarcinoma drug therapy, Esophageal Neoplasms drug therapy, Stomach Neoplasms drug therapy
Abstract

Background: Perioperative chemotherapy (POC) is one standard approach for the treatment of resectable cancers of the stomach and gastroesophageal junction (GEJ), whereas there has been growing interest in preoperative therapies. The objective of the current study was to compare survival between patients treated with preoperative chemoradiotherapy and adjuvant chemotherapy (PCRT) with those receiving POC using a large database., Methods: The National Cancer Data Base was queried for patients diagnosed between 2004 and 2013 with American Joint Committee on Cancer clinical group stage IB to stage IIIC (excluding T2N0 disease) adenocarcinoma of the stomach or GEJ. Patients treated with definitive surgery and POC with or without preoperative radiotherapy of 41 to 54 Gy were included. Overall survival (OS) was defined from the date of definitive surgery and estimated using the Kaplan-Meier method. A total of 14 patient and treatment variables were used for propensity score matching (PSM)., Results: A total of 1048 patients were analyzed: 53.2% received POC and 46.8% received PCRT. The primary tumor site was the GEJ in 69.1% of patients and stomach in 30.9% of patients. The median age of the patients was 60 years, and the median follow-up was 25.8 months. The use of PCRT was associated with a greater pathologic complete response rate of 13.1% versus 8.2% (P = .01). POC was associated with a decreased risk of death in unmatched groups (hazard ratio [HR], 0.83; P = .043). Using PSM cohorts, POC decreased the risk of death with a median OS of 45.1 months versus 31.4 months (HR, 0.70; P = .016). The 2-year OS rate was 72.9% versus 62.5% and the 5-year OS rate was 40.7% versus 33.1% for POC versus PCRT, respectively. Survival favored POC in PSM gastric (HR, 0.41; P = .07) and GEJ (HR, 0.77; P = .08) patient subgroups., Conclusions: The addition of preoperative radiotherapy to POC appears to be associated with an increased risk of death in patients with resectable gastric and GEJ cancers., (© 2019 American Cancer Society.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results